Take Action


Filter By:
“GAO: Feds have to improve oversight to stop drug companies from doling out duplicate 340B, Medicaid discounts”
January 28, 2020
Fierce Healthcare
IN CASE YOU MISSED IT: New Study Finds Hospitals Charge Nearly Two Times More Than Physician Offices for Same Cancer Treatments

New research from the Employee Benefit Research Institute (EBRI) has concluded that payments from private third-party payers for infused cancer medicines are, on average, twice as much when care is provided in hospital outpatient departments (HOPDs) compared with physician offices (POs).

January 22, 2020
IN CASE YOU MISSED IT: New GAO Report Finds Oversight Lacking For 340B Hospitals

A new report from the Government Accountability Office (GAO) has concluded increased oversight is needed to ensure nongovernmental hospitals meet 340B eligibility requirements.

January 15, 2020
“Pharmacy middlemen benefit from drug discount program intended to help poor Ohioans”
January 13, 2020
Columbus Dispatch
“Government watchdog finds lax oversight of 340B discounts”
January 13, 2020
Modern Healthcare
“Community Oncology Clinics Continue to Suffer Due to 340B Drug Discount Program”
January 3, 2020
“Put Vulnerable Patients Before Profit”
December 31, 2019
The Advocate
“Let’s Keep Bad Players from Ruining a Good Program”
November 21, 2019
Arizona Capitol Times